血清型A株髄膜炎菌、A群髄膜炎菌
- 関
- serogroup A meningococci、serogroup A meningococcus
WordNet
- the 1st letter of the Roman alphabet (同)a
- the blood group whose red cells carry the A antigen (同)type_A, group A
PrepTutorEJDIC
- answer / ampere
- arsenicの化学記号
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 髄膜炎菌ワクチンmeningococcal vaccines [show details]
…through 25 years of age . Meningococcal serogroup C vaccines are used in Canada, the United Kingdom, and other countries (Meningitec and NeisVac C) Meningococcal serogroup A vaccines are used in Africa …
- 2. 髄膜炎菌感染の疫学epidemiology of neisseria meningitidis infection [show details]
… two years of age. The largest outbreak of Neisseria meningitidis serogroup C in Africa meningitis belt occurred in 2015; 8500 suspected cases of meningococcal meningitis and 573 deaths were reported to …
- 3. 髄膜炎菌感染の治療および予防treatment and prevention of meningococcal infection [show details]
… be immunized with meningococcal vaccines (both ACYW and serogroup B), if possible at least two weeks prior to administering the first dose of the C5 inhibitor. Invasive meningococcal disease has occurred …
- 4. 脾臓の機能障害がある患者への感染症予防prevention of infection in patients with impaired splenic function [show details]
…The H. influenzae type b vaccine (Hib) The quadrivalent meningococcal conjugate ACWY vaccine series (MenACWY) The monovalent meningococcal serogroup B vaccine series (MenB-4C or MenB-FHbp) Both the pneumococcal …
- 5. 髄膜炎菌の微生物学および病理生物学microbiology and pathobiology of neisseria meningitidis [show details]
…capsules. Serogrouping of meningococcal strains into at least 13 serogroups is based upon the capsular polysaccharide type. The overwhelming majority of disease worldwide is caused by five serogroups: A, B …
English Journal
- Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?
- Hong E, Giuliani MM, Deghmane AE, Comanducci M, Brunelli B, Dull P, Pizza M, Taha MK.SourceInstitut Pasteur, Invasive Bacterial Infections Unit, Paris, France.
- Vaccine.Vaccine.2013 Feb 4;31(7):1113-6. doi: 10.1016/j.vaccine.2012.12.022. Epub 2012 Dec 20.
- A new vaccine, 4CMenB, is composed of surface proteins of Neisseria meningitidis and is aimed to target serogroup B (MenB) isolates. The vaccine components are present in meningococcal isolates of other serogroups allowing potential use against meningococcal isolates belonging to non-B serogroups. I
- PMID 23261039
- Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity.
- Kristiansen PA, Diomandé F, Ba AK, Sanou I, Ouédraogo AS, Ouédraogo R, Sangaré L, Kandolo D, Aké F, Saga IM, Clark TA, Misegades L, Martin SW, Thomas JD, Tiendrebeogo SR, Hassan-King M, Djingarey MH, Messonnier NE, Préziosi MP, Laforce FM, Caugant DA.SourceNorwegian Institute of Public Health.
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.Clin Infect Dis.2013 Feb;56(3):354-63. doi: 10.1093/cid/cis892. Epub 2012 Oct 19.
- Background. The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of 1-29-year-olds in Burkina Faso in 2010. It is not known whether MenAfriVac has an impact on NmA carriage. Methods. We conducted a repeated cross-s
- PMID 23087396
- Transcriptional Regulation of the nadA Gene in Neisseria meningitidis Impacts the Prediction of Coverage of a Multicomponent Meningococcal Serogroup B Vaccine.
- Fagnocchi L, Biolchi A, Ferlicca F, Boccadifuoco G, Brunelli B, Brier S, Norais N, Chiarot E, Bensi G, Kroll JS, Pizza M, Donnelly J, Giuliani MM, Delany I.SourceNovartis Vaccines and Diagnotics, Research Center, Siena, Italy.
- Infection and immunity.Infect Immun.2013 Feb;81(2):560-9. doi: 10.1128/IAI.01085-12. Epub 2012 Dec 10.
- The NadA adhesin is a major component of 4CMenB, a novel vaccine to prevent meningococcus serogroup B (MenB) infection. Under in vitro growth conditions, nadA is repressed by the regulator NadR and poorly expressed, resulting in inefficient killing of MenB strains by anti-NadA antibodies. Interestin
- PMID 23230289
Japanese Journal
- Neisseria meningitidis serogroup Y による髄膜炎の1症例
- 大坪 千麻,吉村 尚江,成田 千加,藤 洋美,川島 博信,大楠 清文,小野 順子,松永 彰
- 医学検査 : 日本臨床衛生検査技師会誌 = The Japanese journal of medical technology 57(12), 1397-1401, 2008-12-25
- NAID 10026955816
- Genetic and Antigenic Characterization of Neisseria meningitidis Strains from Turkish Recruits in 2006
- Kilic Abdullah,Jolley Keith A.,Gul H. Cem,Saracli M Ali,Besirbellioglu Bulent,Basustaoglu A. Celal
- Internal Medicine 47(21), 1949-1950, 2008
- NAID 130000079599
Related Links
- Species, Scientific Experts, Genomes and Genes, Research Grants, Publications, Research Topics about serogroup a neisseria meningitidis ... Summary: Strains of Neisseria meningitidis responsible for most outbreaks of ...
- Neisseria meningitidis serogroup A (type) symptoms, causes, diagnosis, and treatment information for Neisseria meningitidis serogroup A (type) (Meningococcal disease) with alternative diagnoses, full-text book chapters ...
★リンクテーブル★
[★]
- 英
- serogroup A meningococcus、serogroup A meningococci、serogroup A Neisseria meningitidis
- 関
- セログループA髄膜炎菌、A群血清型髄膜炎菌、A群髄膜炎菌
[★]
血清型A株髄膜炎菌、A群血清型髄膜炎菌、セログループA髄膜炎菌
- 関
- serogroup A meningococcus、serogroup A Neisseria meningitidis
[★]
- ラ
- serogroup A Neisseria meningitidis
- 関
- 血清型A株髄膜炎菌
[★]
- 日
- 髄膜炎菌
- 英
- meningococcus
- 関
- 細菌、ナイセリア属
生物的特徴
感染経路
- 高頻度：関節炎
- まれ ：化膿性結膜炎、副鼻腔炎、心内膜炎、肺炎
培養(SMB.215)
- 3-10%CO2存在下で24時間培養
- 血液感染培地、チョコレート培地
[★]
- 関
- serotype、serotypic、serovar
[★]
[★]
髄膜炎
- 関
- meningitic、meningitides、meningitis
[★]
- 関
- adenoviral、adenovirus